Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy
- 22 July 2016
- journal article
- research article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 21 (9), 1124-1130
- https://doi.org/10.1111/tmi.12746
Abstract
OBJECTIVE As guidelines are evolving towards recommending starting antiretroviral therapy (ART) in all HIV-positive individuals irrespective of clinical and immunological status, HIV programmes will be challenged to manage an increasingly diverse set of patient needs. To support global guideline recommendations for differentiated service delivery, WHO developed consensus definitions for two distinct patient populations: patients presenting with advanced disease and patients who are stable on ART. METHODS An expert panel consisting of 73 respondents from 28 countries across all six WHO regions supported the development of these definitions. The panel included clinicians, researchers, programme managers, technical advisors and patient group representatives. RESULTS Patients presenting with advanced disease at presentation to care were defined as CD4 count < 200 CD4 cells/mm(3) or WHO Stage III & IV defining illness. Patients stable on ART were defined as those who were receiving ART for at least 1 year with no adverse drug reactions requiring regular monitoring, no current illnesses or pregnancy, a good understanding of lifelong adherence, and evidence of treatment success. Treatment success was defined as two consecutive undetectable viral load measures or, in the absence of viral load monitoring, rising CD4 counts or CD4 counts above 200 cells/mm(3) and an objective adherence measure. CONCLUSIONS Patients who are stable on ART should be offered a less intensive care package that can lead to improved outcomes while saving resources, including less frequent clinic visits, out-of-clinic drug refills and reduced laboratory monitoring. This will allow for clinic resources to be directed towards reducing morbidity and mortality among patients presenting with advanced disease.Keywords
Funding Information
- Bill and Melinda Gates Foundation
This publication has 39 references indexed in Scilit:
- Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)PLoS Medicine, 2013
- Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South AfricaPLOS ONE, 2013
- A New Multidisciplinary Home Care Telemedicine System to Monitor Stable Chronic Human Immunodeficiency Virus-Infected Patients: A Randomized StudyPLOS ONE, 2011
- Trends in the clinical characteristics of HIV‐infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009Journal of the International AIDS Society, 2011
- Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009AIDS Research and Therapy, 2011
- Late presentation of HIV infection: a consensus definitionHIV Medicine, 2010
- Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapyAIDS, 2010
- Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?AIDS, 2008
- Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort StudyHIV Medicine, 2008
- The Delphi technique: a critiqueJournal of Advanced Nursing, 1987